This dual mechanism triggers a self-reinforcing therapeutic cycle: ferroptosis releases tumor antigens, activating CD8+ T cells to secrete interferon-γ (IFN-γ), which suppresses GPX4 expression and exacerbates LPO, thereby sustaining ferroptotic cell death [144]. The gene discussed is CD8A; the disease is neoplasm.